Literature DB >> 31185411

3,4-Dideoxy-3,3,4,4-tetrafluoro- and 4-OH epimeric 3-deoxy-3,3-difluoro-α-GalCer analogues: Synthesis and biological evaluation on human iNKT cells stimulation.

Samuel Golten1, Allan Patinec2, Katy Akoumany1, Jézabel Rocher2, Jérôme Graton1, Denis Jacquemin1, Jean-Yves Le Questel1, Arnaud Tessier1, Jacques Lebreton1, Virginie Blot1, Muriel Pipelier1, Jean-Yves Douillard3, Jacques Le Pendu2, Bruno Linclau4, Didier Dubreuil5.   

Abstract

iNKT cells recognize CD1d/α-galactosylceramide (α-GalCer) complexes via their invariant TCR receptor and stimulate the immune response. Many α-GalCer analogues have been investigated to interrogate this interaction. Following our previous work related to the modification of the hydrogen bond network between α-GalCer and CD1d, we have now focused our attention on the synthesis of 3-deoxy-3,3-difluoro- and 3,4-dideoxy-3,3,4,4-tetrafluoro-α-GalCer analogues, and studied their ability to stimulate human iNKT cells. In each case, deoxygenation at the indicated positions was accompanied by difluoro introduction in order to evaluate the resulting electronic effect on the stability of the ternary CD1d/Galcer/TCR complex which has been rationalized by modeling study. With deoxy-difluorination at the 3-position, the two epimeric 4-OH analogues were investigated to establish their capacity to compensate for the lack of the hydrogen bond donating group at the 3-position. The 3,4-dideoxytetrafluoro analogue was of interest to highlight the amide NH-bond hydrogen bond properties.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fluoro GalCer analogues; Immune response; Modeling study; iNKT activation

Mesh:

Substances:

Year:  2019        PMID: 31185411     DOI: 10.1016/j.ejmech.2019.05.069

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  1 in total

1.  Synthesis of Difluorinated Halohydrins by the Chemoselective Addition of Difluoroenolates to α-Haloketones.

Authors:  Munia F Sowaileh; Maali D Alshammari; David A Colby
Journal:  Org Lett       Date:  2021-06-14       Impact factor: 6.072

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.